Patents by Inventor Grant Ellsworth Blouse

Grant Ellsworth Blouse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF
    Publication number: 20210230570
    Abstract: Modified Factor IX (FIX) polypeptides and uses thereof are provided. Nucleic acid molecules encoding modified factor IX (FIX) polypeptides and uses thereof also are provided. Such modified FIX polypeptides include FIXa and other forms of FIX. Among the modified FIX polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
    Type: Application
    Filed: March 16, 2021
    Publication date: July 29, 2021
    Inventors: Edwin L. Madison, Christopher Thanos, Grant Ellsworth Blouse
  • Modified factor IX polypeptides and uses thereof
    Patent number: 10982203
    Abstract: Nucleic acid molecules encoding modified factor IX (FIX) polypeptides and uses thereof are provided. Such modified FIX polypeptides include FIXa and other forms of FIX. Among the modified FIX polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: April 20, 2021
    Assignee: Catalyst Biosciences, Inc.
    Inventors: Edwin L. Madison, Christopher Thanos, Grant Ellsworth Blouse
  • MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF
    Publication number: 20160201047
    Abstract: Nucleic acid molecules encoding modified factor IX (FIX) polypeptides and uses thereof are provided. Such modified FIX polypeptides include FIXa and other forms of FIX. Among the modified FIX polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 14, 2016
    Inventors: Edwin L. Madison, Christopher Thanos, Grant Ellsworth Blouse
  • Modified factor IX polypeptides and uses thereof
    Patent number: 9328339
    Abstract: Modified Factor IX (FIX) polypeptides and uses thereof are provided. Such modified FIX polypeptides include FIXa and other forms of FIX. Among the modified FIX polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
    Type: Grant
    Filed: May 1, 2014
    Date of Patent: May 3, 2016
    Assignee: Catalyst Biosciences, Inc.
    Inventors: Edwin L. Madison, Christopher Thanos, Grant Ellsworth Blouse
  • MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF
    Publication number: 20140322191
    Abstract: Modified Factor IX (FIX) polypeptides and uses thereof are provided. Such modified FIX polypeptides include FIXa and other forms of FIX. Among the modified FIX polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
    Type: Application
    Filed: May 1, 2014
    Publication date: October 30, 2014
    Inventors: Edwin L. Madison, Christopher Thanos, Grant Ellsworth Blouse
  • Modified factor IX polypeptides and uses thereof
    Patent number: 8778870
    Abstract: Modified Factor IX (FIX) polypeptides and uses thereof are provided. Such modified FIX polypeptides include FIXa and other forms of FIX. Among the modified FIX polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
    Type: Grant
    Filed: November 3, 2011
    Date of Patent: July 15, 2014
    Assignee: Catalyst Biosciences, Inc.
    Inventors: Edwin L. Madison, Christopher Thanos, Grant Ellsworth Blouse
  • Modified factor IX polypeptides and uses thereof
    Publication number: 20130177541
    Abstract: Modified Factor IX (FIX) polypeptides and uses thereof are provided. Such modified FIX polypeptides include FIXa and other forms of FIX. Among the modified FIX polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
    Type: Application
    Filed: November 3, 2011
    Publication date: July 11, 2013
    Inventors: Edwin L. Madison, Christopher Thanos, Grant Ellsworth Blouse
  • Modified factor IX polypeptides and uses thereof
    Publication number: 20120308540
    Abstract: Modified Factor IX (FIX) polypeptides and uses thereof are provided. Such modified FIX polypeptides include FIXa and other forms of FIX. Among the modified FIX polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.
    Type: Application
    Filed: November 3, 2011
    Publication date: December 6, 2012
    Inventors: Edwin L. Madison, Christopher Thanos, Grant Ellsworth Blouse